You may not experience symptoms of multiple myeloma in the precancerous and early stages. If your cancer advances, the most common symptoms are anemia, bone pain, kidney problems, and ...

Medically reviewed by Lindsay Cook, PharmD Multiple myeloma (also referred to as myeloma) is a type of rare, incurable cancer of the blood—also known as hematologic cancer. It affects cells called ...

Correct diagnosis of solitary plasmacytoma as the cause of gastrointestinal blood loss and anemia is important because ... or other features of multiple myeloma is tumoricidal radiation at a ...

Healthy plasma cells make antibodies that help fight infection. But the myeloma plasma cells make abnormal antibodies. This can make it hard for your body to fight infection. And when there are too ...

The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...

Jan. 14, 2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients.

But every single patient diagnosed with myeloma today must have had these precursor conditions years before. As clinicians, we should be detecting those earlier stages and not waiting for people to ...

Myeloma cells crowd out normal blood cells, lowering your red blood cell count, causing anemia and fatigue. Without treatment, these cells continue to grow and can cause serious complications in ...

Linvoseltamab is an investigational B-cell maturation antigen CD3-targeted bispecific antibody. The BLA resubmission was needed as the original application could not be approved due to manufacturing ...

Multiple myeloma (MM) is a malignant plasma cell disorder ... It was approved in December 2005 for red blood cell transfusion-dependent anemia in patients with low- and intermediate-risk ...